Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Bioinformatics and Computational Biology
|
January 4, 2008
Retrieving mutation-specific information for human proteins in UniProt/Swiss-Prot Knowledgebase
Yum Lina Yip, Nathalie Lachenal, Violaine Pillet, et al.
Trials
|
February 17, 2026
Evaluation of a combined tuberculosis case-finding, treatment and prevention strategy in Thailand: protocol for a pragmatic phase IV stepped-wedge cluster-randomised trial, the CaPThai study
Tamara Tovar Sanchez, Jintana Ngamvithayapong-Yanai, Daniel Grint, et al.
Emerging Infectious Diseases
|
August 3, 2017
Six-Month Response to Delamanid Treatment in MDR TB Patients
Cathy Hewison, Gabriella Ferlazzo, Zaza Avaliani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 20, 2020
One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India
Mrinalini Das, Alpa Dalal, Chinmay Laxmeshwar, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2024
How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial
Ilaria Motta, Martina Cusinato, Andrew J Ludman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 18, 2025
The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan
Animesh Sinha, Roland Klebe, Michael L Rekart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2023
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs
Ismat Lotia Farrukh, Nathalie Lachenal, Malik M Adenov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 14, 2022
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
Catherine Hewison, Uzma Khan, Mathieu Bastard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 4, 2022
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs
Helena Huerga, Uzma Khan, Mathieu Bastard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2024
The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort
Uzma Khan, Michael Rich, Molly Franke, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Bioinformatics and Computational Biology
|
January 4, 2008
Retrieving mutation-specific information for human proteins in UniProt/Swiss-Prot Knowledgebase
Yum Lina Yip, Nathalie Lachenal, Violaine Pillet, et al.
Trials
|
February 17, 2026
Evaluation of a combined tuberculosis case-finding, treatment and prevention strategy in Thailand: protocol for a pragmatic phase IV stepped-wedge cluster-randomised trial, the CaPThai study
Tamara Tovar Sanchez, Jintana Ngamvithayapong-Yanai, Daniel Grint, et al.
Emerging Infectious Diseases
|
August 3, 2017
Six-Month Response to Delamanid Treatment in MDR TB Patients
Cathy Hewison, Gabriella Ferlazzo, Zaza Avaliani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 20, 2020
One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India
Mrinalini Das, Alpa Dalal, Chinmay Laxmeshwar, et al.
Antimicrobial Agents and Chemotherapy
|
June 6, 2024
How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial
Ilaria Motta, Martina Cusinato, Andrew J Ludman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 18, 2025
The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan
Animesh Sinha, Roland Klebe, Michael L Rekart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2023
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs
Ismat Lotia Farrukh, Nathalie Lachenal, Malik M Adenov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 14, 2022
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
Catherine Hewison, Uzma Khan, Mathieu Bastard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 4, 2022
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs
Helena Huerga, Uzma Khan, Mathieu Bastard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2024
The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort
Uzma Khan, Michael Rich, Molly Franke, et al.
Page
of 2